These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

650 related articles for article (PubMed ID: 27222041)

  • 21. Classifications of ovarian cancer tissues by proteomic patterns.
    Zhu Y; Wu R; Sangha N; Yoo C; Cho KR; Shedden KA; Katabuchi H; Lubman DM
    Proteomics; 2006 Nov; 6(21):5846-56. PubMed ID: 17068758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ADAM Metalloprotease-Released Cancer Biomarkers.
    Herrlich P; Herrlich A
    Trends Cancer; 2017 Jul; 3(7):482-490. PubMed ID: 28718403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of proteomics-identified CCL18 and CXCL1 as circulating tumor markers for differential diagnosis between ovarian carcinomas and benign pelvic masses.
    Wang Q; Li D; Zhang W; Tang B; Li QQ; Li L
    Int J Biol Markers; 2011; 26(4):262-73. PubMed ID: 21928244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of serum biomarkers of ovarian cancer using complementary proteomic profiling strategies.
    Timms JF; Arslan-Low E; Kabir M; Worthington J; Camuzeaux S; Sinclair J; Szaub J; Afrough B; Podust VN; Fourkala EO; Cubizolles M; Kronenberg F; Fung ET; Gentry-Maharaj A; Menon U; Jacobs I
    Proteomics Clin Appl; 2014 Dec; 8(11-12):982-93. PubMed ID: 25290619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of proteomics in ovarian cancer: which sample should be used?
    Cadron I; Van Gorp T; Timmerman D; Amant F; Waelkens E; Vergote I
    Gynecol Oncol; 2009 Dec; 115(3):497-503. PubMed ID: 19811810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathological study of metallothionein immunohistochemical expression, in benign, borderline and malignant ovarian epithelial tumors.
    Zagorianakou N; Stefanou D; Makrydimas G; Zagorianakou P; Briasoulis E; Karavasilis V; Pavlidis N; Agnantis NJ
    Histol Histopathol; 2006 Apr; 21(4):341-7. PubMed ID: 16437378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteomic analyses of serous and endometrioid epithelial ovarian cancers - cases studies - molecular insights of a possible histological etiology of serous ovarian cancer.
    Longuespée R; Gagnon H; Boyon C; Strupat K; Dauly C; Kerdraon O; Ighodaro A; Desmons A; Dupuis J; Wisztorski M; Vinatier D; Fournier I; Day R; Salzet M
    Proteomics Clin Appl; 2013 Jun; 7(5-6):337-54. PubMed ID: 23589350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of the clinicopathological relevance of mesothelin level in plasma, peritoneal fluid, and tumor tissue of epithelial ovarian cancer patients.
    Okła K; Surówka J; Frąszczak K; Czerwonka A; Kaławaj K; Wawruszak A; Kotarski J; Wertel I
    Tumour Biol; 2018 Oct; 40(10):1010428318804937. PubMed ID: 30319054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and validation of differential plasma proteins levels in epithelial ovarian cancer.
    Periyasamy A; Gopisetty G; Subramanium MJ; Velusamy S; Rajkumar T
    J Proteomics; 2020 Aug; 226():103893. PubMed ID: 32634479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential proteomic approach for identification and verification of aberrantly glycosylated proteins in adenocarcinoma lung cancer (ADLC) plasmas by lectin-capturing and targeted mass spectrometry.
    Ahn YH; Ji ES; Oh NR; Kim YS; Ko JH; Yoo JS
    J Proteomics; 2014 Jun; 106():221-9. PubMed ID: 24780727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteomic approaches to tumor marker discovery.
    Rai AJ; Zhang Z; Rosenzweig J; Shih IeM; Pham T; Fung ET; Sokoll LJ; Chan DW
    Arch Pathol Lab Med; 2002 Dec; 126(12):1518-26. PubMed ID: 12456215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteomic studies of early-stage and advanced ovarian cancer patients.
    Wang J; Zhang X; Ge X; Guo H; Xiong G; Zhu Y
    Gynecol Oncol; 2008 Oct; 111(1):111-9. PubMed ID: 18703221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein expression patterns associated with advanced stage ovarian cancer.
    Cortesi L; Rossi E; Della Casa L; Barchetti A; Nicoli A; Piana S; Abrate M; La Sala GB; Federico M; Iannone A
    Electrophoresis; 2011 Aug; 32(15):1992-2003. PubMed ID: 21728179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and validation of salivary proteomic signatures for non-invasive detection of ovarian cancer.
    Tajmul M; Parween F; Singh L; Mathur SR; Sharma JB; Kumar S; Sharma DN; Yadav S
    Int J Biol Macromol; 2018 Mar; 108():503-514. PubMed ID: 29222021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proximal fluid proteomics for the discovery of digestive cancer biomarkers.
    Farina A
    Biochim Biophys Acta; 2014 May; 1844(5):988-1002. PubMed ID: 24184935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using proteomic approaches to identify new biomarkers for detection and monitoring of ovarian cancer.
    Kong F; Nicole White C; Xiao X; Feng Y; Xu C; He D; Zhang Z; Yu Y
    Gynecol Oncol; 2006 Feb; 100(2):247-53. PubMed ID: 16229881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Translational Research and Plasma Proteomic in Cancer.
    Santini AC; Giovane G; Auletta A; Di Carlo A; Fiorelli A; Cito L; Astarita C; Giordano A; Alfano R; Feola A; Di Domenico M
    J Cell Biochem; 2016 Apr; 117(4):828-35. PubMed ID: 26479787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of ovarian cancer-associated proteins in symptomatic women: A novel method for semi-quantitative plasma proteomics.
    Shield-Artin KL; Bailey MJ; Oliva K; Liovic AK; Barker G; Dellios NL; Reisman S; Ayhan M; Rice GE
    Proteomics Clin Appl; 2012 Apr; 6(3-4):170-81. PubMed ID: 22532453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The serine protease prostasin (PRSS8) is a potential biomarker for early detection of ovarian cancer.
    Tamir A; Gangadharan A; Balwani S; Tanaka T; Patel U; Hassan A; Benke S; Agas A; D'Agostino J; Shin D; Yoon S; Goy A; Pecora A; Suh KS
    J Ovarian Res; 2016 Mar; 9():20. PubMed ID: 27036110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of potential protein biomarkers of lung adenocarcinoma in bronchoalveolar lavage fluid by SWATH MS data-independent acquisition and targeted data extraction.
    Ortea I; Rodríguez-Ariza A; Chicano-Gálvez E; Arenas Vacas MS; Jurado Gámez B
    J Proteomics; 2016 Apr; 138():106-14. PubMed ID: 26917472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.